R87.61ActuelleCatégorie · précision supplémentaire requise

Abnormal cytological findings in specimens from cervix uteri

Instructions du code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

R83-R89 · Instructions des niveaux supérieurs

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.61

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Codes plus précis

R87.610Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)R87.611Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)R87.612Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)R87.613High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)R87.614Cytologic evidence of malignancy on smear of cervix R87.615Unsatisfactory cytologic smear of cervix R87.616Satisfactory cervical smear but lacking transformation zone R87.618Other abnormal cytological findings on specimens from cervix uteri R87.619Unspecified abnormal cytological findings in specimens from cervix uteri

Facturation et couverture

Quand ICD-10-CM est obligatoire

Pour les demandes de remboursement américaines soumises à HIPAA, ICD-10-CM est obligatoire pour les diagnostics depuis le 1er octobre 2015.

Utilisez la date des soins en ambulatoire et pour les actes professionnels, et la date de sortie pour les séjours hospitaliers. Les soins antérieurs relèvent d’ICD-9-CM ; chaque code doit aussi être valable à la date concernée.

Directives officielles de codage → · CMS ↗

Première observation · 2015-10-01

Historique du code

Aucune modification depuis la première observation

ModifiéInchangé

FY2016

En vigueur dès le 2015-10-01

Première observation

Abnormal cytological findings in specimens from cervix uteri

Catégorie — choisir un code plus précis

CDC/NCHS · FY2016

Toutes les éditions (19)

Toutes les éditions	En vigueur dès le	Historique du code
FY2016	2015-10-01	Première observation
FY2017	2016-10-01	Aucun changement tabulaire
FY2018	2017-10-01	Aucun changement tabulaire
FY2019	2018-10-01	Aucun changement tabulaire
FY2020	2019-10-01	Aucun changement tabulaire
FY2020 · April	2020-04-01	Aucun changement tabulaire
FY2021	2020-10-01	Aucun changement tabulaire
FY2021 · 01-01	2021-01-01	Aucun changement tabulaire
FY2022	2021-10-01	Aucun changement tabulaire
FY2022 · 04-01	2022-04-01	Aucun changement tabulaire
FY2023	2022-10-01	Aucun changement tabulaire
FY2023 · 04-01	2023-04-01	Aucun changement tabulaire
FY2024	2023-10-01	Aucun changement tabulaire
FY2024 · 04-01	2024-04-01	Aucun changement tabulaire
FY2025	2024-10-01	Aucun changement tabulaire
FY2025 · 04-01	2025-04-01	Aucun changement tabulaire
FY2026	2025-10-01	Aucun changement tabulaire
FY2026 · April	2026-04-01	Aucun changement tabulaire
FY2027	2026-10-01	Aucun changement tabulaire

Instructions du code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Instructions des niveaux supérieurs

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Codes plus précis

Codes associés

Autres entrées de la même catégorie ; elles ne sont pas des substituts automatiques.

Code	Description	Catégorie · précision supplémentaire requise
R87.62	Abnormal cytological findings in specimens from vagina	Catégorie · précision supplémentaire requise
R87.69	Abnormal cytological findings in specimens from other female genital organs	Code facturable et spécifique

Les intitulés et instructions officiels sont conservés dans la langue source. Sources officielles ↗

R87.61ActuelleCatégorie · précision supplémentaire requise

Abnormal cytological findings in specimens from cervix uteri

Instructions du code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

R83-R89 · Instructions des niveaux supérieurs

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.61

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Codes plus précis

Facturation et couverture

Quand ICD-10-CM est obligatoire

Pour les demandes de remboursement américaines soumises à HIPAA, ICD-10-CM est obligatoire pour les diagnostics depuis le 1er octobre 2015.

Directives officielles de codage → · CMS ↗

Première observation · 2015-10-01

Historique du code

Aucune modification depuis la première observation

ModifiéInchangé

FY2016

En vigueur dès le 2015-10-01

Première observation

Abnormal cytological findings in specimens from cervix uteri

Catégorie — choisir un code plus précis

CDC/NCHS · FY2016

Toutes les éditions (19)

Toutes les éditions	En vigueur dès le	Historique du code
FY2016	2015-10-01	Première observation
FY2017	2016-10-01	Aucun changement tabulaire
FY2018	2017-10-01	Aucun changement tabulaire
FY2019	2018-10-01	Aucun changement tabulaire
FY2020	2019-10-01	Aucun changement tabulaire
FY2020 · April	2020-04-01	Aucun changement tabulaire
FY2021	2020-10-01	Aucun changement tabulaire
FY2021 · 01-01	2021-01-01	Aucun changement tabulaire
FY2022	2021-10-01	Aucun changement tabulaire
FY2022 · 04-01	2022-04-01	Aucun changement tabulaire
FY2023	2022-10-01	Aucun changement tabulaire
FY2023 · 04-01	2023-04-01	Aucun changement tabulaire
FY2024	2023-10-01	Aucun changement tabulaire
FY2024 · 04-01	2024-04-01	Aucun changement tabulaire
FY2025	2024-10-01	Aucun changement tabulaire
FY2025 · 04-01	2025-04-01	Aucun changement tabulaire
FY2026	2025-10-01	Aucun changement tabulaire
FY2026 · April	2026-04-01	Aucun changement tabulaire
FY2027	2026-10-01	Aucun changement tabulaire

Instructions du code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Instructions des niveaux supérieurs

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Codes plus précis

Codes associés

Autres entrées de la même catégorie ; elles ne sont pas des substituts automatiques.

Code	Description	Catégorie · précision supplémentaire requise
R87.62	Abnormal cytological findings in specimens from vagina	Catégorie · précision supplémentaire requise
R87.69	Abnormal cytological findings in specimens from other female genital organs	Code facturable et spécifique

Les intitulés et instructions officiels sont conservés dans la langue source. Sources officielles ↗